Related Experiment Video
Updated: Jun 23, 2026
Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
Macrophage Migration Inhibitory Factor in Major Depressive Disorder: A Multilevel Pilot Study
Caroline Swoboda1, Lena Deloch1, Claudia von Zimmermann1
1Department of Psychiatry and Psychotherapy, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Schwabachanlage 6, D-91054 Erlangen, Germany.
Abstract:
Macrophage migration inhibitory factor (MIF) is a controversially discussed inflammatory marker in major depressive disorder (MDD). While some studies show an association of high MIF protein levels with depression, animal models have yielded conflicting results. Thus, it remains elusive as to whether MIF plays an anti- or pro-depressive role. Therefore, we aimed to examine the potential of MIF at the genetic, expression and protein levels as a risk factor and biomarker to diagnose, monitor, or predict the course of MDD. Patients with a current major depressive episode (n = 66 with, and n = 63 without, prior medication) and remitted patients (n = 39) were compared with healthy controls (n = 61). Currently depressed patients provided a second blood sample after three weeks of therapy. Depression severity was assessed by self-evaluation and clinician rating scales. We genotyped for three MIF polymorphisms and analyzed peripheral MIF expression and serum levels. The absence of minor allele homozygous individuals in the large group of 96 female patients compared with 10-16% in female controls suggests a protective effect for MDD, which was not observed in the male group. There were no significant group differences of protein and expression levels, however, both showed predictive potential for the course of depression severity in some subgroups. While MIF protein levels, but not MIF expression, decreased during treatment, they were not associated with changes in depression severity. This project is the first to investigate three biological levels of MIF in depression. The data hint toward a genetic effect in women, but do not provide robust evidence for the utility of MIF as a biomarker for the diagnosis or monitoring of MDD. The observed predictive potential requires further analysis, emphasizing future attention to confounding factors such as sex and premedication.
Insights
Macrophage migration inhibitory factor (MIF) may have a protective genetic effect in women with major depressive disorder (MDD). However, MIF is not a reliable biomarker for diagnosing or monitoring MDD in general.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Macrophage migration inhibitory factor (MIF) is a debated inflammatory marker in major depressive disorder (MDD).
- Conflicting results exist regarding MIF's role (anti- or pro-depressive) in MDD.
- Previous research has not comprehensively investigated MIF at genetic, expression, and protein levels in MDD.
Purpose of the Study:
- To investigate the potential of MIF as a risk factor and biomarker for diagnosing, monitoring, or predicting the course of MDD.
- To examine MIF at genetic, expression, and protein levels in patients with current or remitted MDD compared to healthy controls.
- To explore the influence of sex and prior medication on MIF's role in MDD.
Main Methods:
- Genotyping of three MIF polymorphisms in 267 participants (66 currently depressed, 63 depressed without prior medication, 39 remitted, 61 controls).
- Analysis of peripheral MIF expression and serum levels in patient subgroups and controls.
- Assessment of depression severity using self-evaluation and clinician rating scales, with repeated measures after three weeks of therapy for currently depressed patients.
Main Results:
- Absence of minor allele homozygous individuals in female MDD patients suggests a potential protective genetic effect, not observed in males.
- No significant group differences in overall MIF protein or expression levels.
- MIF protein levels decreased during treatment, but neither protein nor expression levels correlated with changes in depression severity.
- MIF levels showed potential predictive value for depression course in specific subgroups.
Conclusions:
- The study suggests a possible genetic influence of MIF in female MDD patients but does not support its use as a robust biomarker for MDD diagnosis or monitoring.
- The predictive potential of MIF warrants further investigation, considering confounding factors like sex and prior medication.
- This research is the first to explore MIF across genetic, expression, and protein levels in depression, highlighting the need for nuanced interpretation.
Related Concept Videos
01:27Depressive Disorders: MDD and Dysthymia
01:27Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...